Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000523574 | SCV000619264 | uncertain significance | not provided | 2017-07-31 | criteria provided, single submitter | clinical testing | The G3855C variant in the KIAA1109 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The G3855C variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The G3855C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret G3855C as a variant of uncertain significance. |
Ambry Genetics | RCV004601193 | SCV005101976 | uncertain significance | not specified | 2024-03-28 | criteria provided, single submitter | clinical testing | The c.11563G>T (p.G3855C) alteration is located in exon 66 (coding exon 66) of the KIAA1109 gene. This alteration results from a G to T substitution at nucleotide position 11563, causing the glycine (G) at amino acid position 3855 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |